Search
for
Sort by
Research 181–210 of 579
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Novel therapies for alopecia areata: The era of rational drug development
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Role of skin enzymes in metabolism of topical drugs
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Sulforaphane, L-Menthol, and Dexpanthenol as a Novel Active Cosmetic Ingredient Composition for Relieving Hair Loss Symptoms
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Association between genetically predicted rheumatoid arthritis and alopecia areata: a two-sample Mendelian randomization study
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Dermatologic Adverse Events from Cancer Treatments
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets